Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India

B. N. B. M. Prasad, S. P. Rai, J. J. Falleiro, V. Ravishankar (Pune, India)

Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Session: Multi/extensively-drug resistant tuberculosis
Session type: Oral Presentation
Number: 4447
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. N. B. M. Prasad, S. P. Rai, J. J. Falleiro, V. Ravishankar (Pune, India). Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India. Eur Respir J 2009; 34: Suppl. 53, 4447

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006

Does the radiological manifestation of drug resistant pulmonary tuberculosis (PTB) in HIV non-infected/infected patients differ – an Indian picture
Source: Eur Respir J 2007; 30: Suppl. 51, 440s
Year: 2007

Adults without HIV infection hospitalised for tuberculosis – Clinical and drug sensitivity profiles
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011


Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003

Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Side effects at second line TB drugs – 2 years experience of multidrug-resistant tuberculosis department from Bucharest
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010

HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007



Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Antituberculosis drug-induced hepatotoxicity: influence on the management and outcome of active tuberculosis (TB)
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


A two-year post-treatment follow-up of multi-drug resistant tuberculosis cases who completed a programmatic MDR-TB management at the lung center of the Philippines – a preliminary report
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009



The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012